Planta Med 2021; 87(15): 1279
DOI: 10.1055/s-0041-1736877
Abstracts
8. Poster Contributions
8.5 Translational natural product pharmacology

Cirsium palustre extracts as potential modifiers of colon motility in functional gut disorders – an ex vivo study

Dominika Szadkowska
1   Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
,
Martyna Posłuszny
1   Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
,
Magdalena Chłopecka
1   Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
,
W. Jakub Strawa
2   Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Białystok, Poland.
,
Katarzyna Jakimiuk
2   Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Białystok, Poland.
,
Michał Tomczyk
2   Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, Białystok, Poland.
,
Marta Mendel
1   Institute of Veterinary Medicine, Warsaw University of Life Sciences, Warsaw, Poland
› Author Affiliations
 

Inflammatory bowel disease and many other functional gastrointestinal disorders represent a modern global threat to human health. Due to the complex etiology of the problem, the available treatment methods do not completely cure the disease and thus are not entirely satisfactory, and new treatment alternatives are intensively searched for. Thus, the study was aimed to verify the usefulness of Cirsium palustre (L.) Scop. (Asteraceae) extracts to modify colon dysmotility. The experiments were performed on an alternative experimental model of swine colon specimens, which can be used in translational medicine. Intestine preparations were incubated in modified Krebs-Henseleit solution under isometric conditions. The experiments included evaluating the effect of methanolic and 50% methanolic extracts of C. palustre on the spontaneous and acetylcholine(ACh)-induced contractility of colon smooth muscle [1]. An analytical approach based on LC-ESI-MS was applied to obtain a metabolite profile of analyzed extracts. The results revealed significant and dose-dependent potency of both C. palustre extracts to modify colon motoric activity. Both

extracts increased dose-dependently (0.00001-0.1 mg/mL), the spontaneous colon contractility reached over 1.5 fold enhancement of primary activity compared to the control treatment. The opposite effect of both extracts was observed in the case of ACh-evoked contractility. C. palustre decreased the magnitude of ACh-induced reaction dose-dependently. In the case of methanolic extract, the reduction was slightly more potent and resulted in a reaction amounting to approx. 60% of control ACh contraction. The results of the performed study indicate that C. palustre can be considered a valuable, antispasmodic agent to address gastrointestinal hypermotility problems.



Publication History

Article published online:
13 December 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Mendel M., Chłopecka M., Latek U., Karlik W., Tomczykowa M., Strawa J., Tomczyk M. Evaluation of the effects of Bidens tripartita extracts and their main constituents on intestinal motility – an ex vivo study. J Ethnopharmacol 2020; 259: 112982